The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
24
No.
33
September 04, 1998
- The March To Deliver Message Of Funding For Cancer Research, Access To Care
- In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC
- The March, Sept. 26: Events Planned In D.C., Around The U.S.
- NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal
TCL
Vol.
24
No.
34
September 11, 1998
- Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”
- In Brief: Karmanos Institute Names Four To Faculty; $1.5M Donated To Kaplan Cancer Center
- In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers
- NCI Programs: Institute Seeks White Papers On Technology
TCL
Vol.
24
No.
35
September 18, 1998
- NIH Forming Special Emphasis Panel To Review Clinical Oncology Grants
- In Brief: Hutchinson Awarded $8 Million Grant For Pancreatic, Colorectal Cancer Studies
- Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent
- New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval
- In Congress: NCI Apologizes For Delay In Report On Radioactive Fallout
TCL
Vol.
24
No.
36
September 25, 1998
- The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data
- Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies
- Special Report: Politicla Pressure, System Loopholes, Enabled Burzynski To Avoid Usuals
- Scientific Process
- “Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says
- Reviewers Note Major Flaws In Design Of Burzynski’s Trials
- Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”
- Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic
TCL
Vol.
24
No.
37
October 02, 1998
- The March Attracts Thousands To Rally For Research Funding, Access To Care
- In Brief: NCCS Honors 14 Who Make A Difference; Lasker Awards Presented To Seven Scientists
- The March: Research Task Force Calls For $10 Billion NCI Budget In 5 Years
- It’s “High Noon” For Cancer, Vice President Says
- In Radio Address, Clinton Outlines Administration Priorities
- “We Will Move Forward With Bold Expectations,” NCI Director Says
TCL
Vol.
24
No.
38
October 09, 1998
- Clinical Trials Streamlining Moves Forward; NCI Commits To Full Funding For Groups
- In Brief: NSABP Selects 193 Institutions For STAR; ACR Names Evens, Ramsey As New Officers
- Professional Societies: Organizations Form Alliance To Call For Quality Cancer Care
- News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors
- The White House: President’s Proclamation For Breast Cancer Awareness Month
- NCI Programs: 15 New Grants Awarded In Survivor Research
TCL
Vol.
24
No.
39
October 16, 1998
- NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years
- In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant
- In Congress: Continuing Resolutions Keep Feds Running; Henney Nomination Stalled By Nickles
- Professional Societies: AACI Seeks To Define Role Of Cancer Centers In Washington Politics
TCL
Vol.
24
No.
40
October 23, 1998
- Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session
- In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner
- The March: Research Task Force Calls For $10 Billion For NCI In 5 Years
- NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure